Prostate Cancer - Results from #25260

Management of prostate cancer patients with lymph node involvement: A rapidly evolving paradigm - Abstract August 1, 2012

Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients - Abstract August 1, 2012

The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer - Abstract August 1, 2012

Incidentally found prostate cancer and influence on overall survival after radical cystoprostatectomy - Abstract August 1, 2012

NIH State-of-the-Science Conference: Role of active surveillance in the management of men with localized prostate cancer August 1, 2012

Efficacy and safety of denosumab for the treatment of bone metastases in patients with advanced cancer - Abstract August 1, 2012

Bone micro-environment in prostate cancer: impact, treatment and implications for nursing practice - Abstract August 1, 2012

Beyond prostate-specific antigen - Future biomarkers for the early detection and management of prostate cancer - Abstract August 1, 2012

Clinical evaluation of lower urinary tract symptoms following seed implant for prostate cancer - Abstract August 1, 2012

Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome - Abstract August 1, 2012

Salvage radiotherapy after high intensity focused ultrasound for prostate cancer - Abstract August 1, 2012

Prostate cancer mortality risk in relation to working underground in the Wismut cohort study of German uranium miners, 1970-2003 - Abstract August 1, 2012

A randomised controlled trial of a cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN): Trial protocol - Abstract August 1, 2012

PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience - Abstract August 1, 2012

Indications for and anatomical extent of pelvic lymph node dissection for prostate cancer: Practice patterns of uro-oncologists in North America - Abstract August 1, 2012

Robustness of ProsVue™ linear slope for prognostic identification of patients at reduced risk for prostate cancer recurrence: Simulation studies on effects of analytical imprecision and sampling time variation - Abstract August 1, 2012

Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer - Abstract August 1, 2012

Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer - Abstract August 1, 2012

A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer - Abstract August 1, 2012

Priapism as the initial manifestation of a penile and lower limb cutaneous metastasis of prostate adenocarcinoma with low serum PSA level: A case report - Abstract August 1, 2012

Page 1264 of 1436